Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
A Finnish study followed patients for 10 years after they had a popular knee surgery. For many, the pain continued or even worsened.
The independent source for health policy research, polling, and news.
1 - 20 of 3,363 Results
A Finnish study followed patients for 10 years after they had a popular knee surgery. For many, the pain continued or even worsened.
One of California’s largest healthcare unions is sponsoring two initiatives that would regulate community clinics and cap executive and managerial pay at hospitals and physician groups. In the most recent eruption of a long-standing feud, the measures have drawn fierce opposition from a wide swath of the medical industry.
Genesis HealthCare’s bankruptcy case in Dallas will allow the nursing home chain to avoid paying millions of dollars it promised for residents who were injured or died while in its care. Families say bankruptcy nullifies one of the main ways to hold nursing home owners accountable for poor care.
On the "Today, Explained" podcast, KFF Health News' Julie Rovner recaps the TrumpRx announcement and why the direct-to-consumer initiative may not save you money on prescription drugs if you have insurance through your employer or the government.
The renowned research hospital that cares for people with rare or life-threatening diseases has been pummeled by an employee exodus and the gutting of research, both driven by the Trump administration.
Sixty percent of Americans have health insurance through their own workplace or someone else’s job. But not all employers provide health insurance or offer plans to all their workers. When they do, cost and quality vary widely, making Thune’s statement an oversimplification.
A stressed primary care system has led many doctors to start practices that charge membership fees in exchange for shorter waits and longer appointments. Observers say the doctor shortage needs a more systemic fix.
More than 60,000 people bleed to death every year in the United States. Many of those deaths occur before the patient reaches a trauma center where blood transfusions can be given.
State legislatures nationwide, including several in the South, are spending millions to improve rural health outcomes and access. For years, though, most Southern states have refused billions of federal dollars to provide public health insurance to more low-income adults. That isn’t likely to change with Trump back in office.
Telehealth startups including Ro and Nurx are spending millions to promote themselves as easy dispensers of medicines. Some companies offer care for birth control, sexual dysfunction, and more complex conditions, including behavioral health disorders and obesity.
Two Indiana hospital rivals withdrew their application to merge after facing pushback from the Federal Trade Commission and the public.
Hundreds of people and the Federal Trade Commission weighed in on a proposed hospital merger in Terre Haute, Indiana, with most arguing that the creation of a monopoly would increase costs and worsen patient care.
Americans are getting dental implants more than ever — and at costs reaching tens of thousands of dollars. Experts worry some dentists have lost sight of the soul of dentistry: preserving and fixing teeth.
Extended-stay hotels are often a last resort for low-income families trying to avoid homelessness. But hotel living can lead to — or exacerbate — various physical and mental health issues for children, say advocates for families and researchers who study homelessness.
New court filings and lobbying reports reveal an industry drive to tamp down critics — and retain billions of dollars in overcharges.
Ballad Health, a 20-hospital system with the nation's largest state-sanctioned hospital monopoly, serves patients in Tennessee, Virginia, Kentucky, and North Carolina.
The Biden administration set stringent new federal staffing rules. But for years, nursing homes have failed to meet the toughest standards set by states.
Increasingly, Americans pay for the privilege of seeing a doctor. Research shows concierge medicine can further hamper access to care for those who can’t afford the upgrade.
The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.
Hospitals are increasingly stretching a velvet rope, offering “concierge service” to an affluent clientele. Critics say the practice exacerbates primary care shortages.
© 2026 KFF